Lung Cancer Voices: Recent Episodes
Lung Cancer Canada
In this episode, Dr. Paul Wheatley-Price talks with Dr. Alexander Louie, Radiation Oncologist at Sunnybrook Health Sciences Center, and Associate Professor of Radiation Oncology at University of Toronto. They chat all about what is radiotherapy, when and how is it used to treat lung cancer, side effects of radiation, and the newest technologies that are changing the game.
Dans cet épisode, la Dre Nathalie Daaboul s’entretient avec Erica Geertsen, fille de Nina Devito, une patiente québécoise, défenseure infatigable de la communauté du cancer du poumon, ainsi que co-présidente du Groupe Exon 20 Canada. Erica revient sur le parcours de sa mère, l’impact de la maladie sur leur famille et la façon dont Nina a transformé son expérience en engagement pour la recherche, l’accès aux traitements et le soutien aux autres patients. Elles parlent également de la force de la communauté, de la résilience et de la manière dont Erica poursuit aujourd’hui l’héritage de sa mère.
In this episode. Dr. Paul Wheatley-Price talks to Dr. Rob Rutledge about the importance of having a wholistic approach to cancer recovery, including diet, exercise, strength training, and mental health, as well as the role of patient empowerment. Dr. Rutledge is Radiation Oncologist at Queen Elizabeth II Health Sciences Center in Halifax, and co-creator of the Cancer Patient Empowerment Program (Cancer PEP) that focuses on education and empowerment for patients living with cancer. Learn more at https://cancerpep.org/
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Tony Mok, Li Shu Fan Professor in the Department of Clinical Oncology at the Chinese University of Hong Kong, to break down some of the biggest lung cancer highlights from the 2026 ASCO Conference, held in Chicago this June. Together, they discuss new research on targeted treatment after surgery for RET-positive lung cancer, immunotherapy for advanced squamous NSCLC, and a long-term update on first-line targeted therapy for ALK-positive lung cancer. They also look ahead to emerging research coming up in KRAS-mutated lung cancer!
Dans cet épisode, la Dre Nathalie Daaboul s’entretient avec le Dr Nicolas Marcoux, hémato-oncologue au CHU Hôtel Dieu de Québec, afin de mieux comprendre le rôle des biomarqueurs et des tests moléculaires dans le traitement du cancer du poumon. Ensemble, ils expliquent pourquoi ces analyses sont essentielles pour orienter les choix de traitement, comment les thérapies ciblées et les biopsies liquides transforment la prise en charge, les défis liés à l’accès et aux délais de dépistage moléculaire, et pourquoi une approche personnalisée, rapide et multidisciplinaire est essentielle pour offrir aux patients le bon traitement au bon moment.
, sharing his leading clinical expertise on the treatment of EGFR-positive lung cancer as Director of the Thoracic Oncology at the University of Colorado Cancer Center. On the other hand, being diagnosed with the same disease himself at stage 4 in 2022, Dr. Camidge shares his perspective and journey from the patient lens, walking in the same shoes that he'd built his career upon. Don't miss this unique episode!
La Dre Nathalie Daaboul s’entretient avec Eva dans cet épisode, qui raconte son parcours après un diagnostic de cancer du poumon reçu en janvier 2020, alors qu’elle menait une vie active et faisait déjà un effort important pour prendre soin de sa santé. Elle partage son expérience avec la radiothérapie et l’immunothérapie, l’importance d’être à l’écoute de son corps, ainsi que la façon dont le cancer a transformé sa vision de la vie. Depuis son diagnostic, Eva demeure également engagée dans la communauté du cancer du poumon, notamment en contribuant à des initiatives de sensibilisation et de soutien aux patients.
In this episode, Dr. Paul Wheatley-Price talks to Dr. Sara Moore about her work and experience in caring for Inuit populations in Nunavut affected by lung cancer. What is the scope of the populations she treats, the unique access barriers for diagnostics and treatment, and how their lung cancer experiences may differ than those living in Southern Canada. Dr. Moore is an Assistant Professor at University of Ottawa, Medical Oncologist and Lung Disease Site Lead at The Ottawa Hospital.
Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec la Dre Arielle Elkrief, oncologue et chercheuse-clinicienne, co-directrice du Centre de microbiome du CHUM, sur le rôle fascinant du microbiome intestinal dans la lutte contre le cancer. Qu'est-ce que le microbiome exactement, comment se développe-t-il au fil de notre vie, quels facteurs peuvent le perturber, quel est son lien avec l'immunothérapie en cancer du poumon, pourquoi faut-il éviter les antibiotiques non nécessaires et les probiotiques en capsules, et qu'est-ce que la greffe fécale peut changer pour les patients en oncologie?
In today's episode, Dr. Paul Wheatley-Price chats with Dr. Natasha Leighl, Medical Oncologist and Lung Site Lead at the Princess Margaret Cancer Center in Toronto, all about liquid biopsies. What is a biopsy, the difference between a tissue vs liquid biopsy, how does it work, when it can be done, and where is it available in Canada? Dr. Leighl gets into all the details with her renowned expertise in this topic!
In this episode, Dr. Paul Wheatley-Price speaks with Dr. Christian Finley, Co-Chair of the Pan-Canadian Lung Cancer Action Plan Steering Committee and Professor at McMaster University. They explore the newly released 2026–2035 Pan-Canadian Lung Cancer Action Plan - an ambitious national roadmap to reduce lung cancer deaths by 30% over the next decade. Lung Cancer Canada has been actively involved on the Steering Committee helping shape the Plan, and continues to be engaged as this work moves into implementation.Learn more at https://cancer.ca/en/about-us/lung-cancer-action-plan
Dans cet épisode, Dre Nathalie Daaboul s’entretient avec Mme Annick Dufour, pharmacienne en oncologie à l'Hôpital Charles-Le Moyne à Montreal, à propos du rôle essentiel des pharmaciens dans la prise en charge du cancer du poumon. Ensemble, elles expliquent en quoi consiste la pharmacie en oncologie, comment les pharmaciens collaborent avec l’équipe médicale, et leur rôle dans la préparation, la validation et l’ajustement des traitements. Elles abordent également la gestion des effets secondaires, l’importance du suivi des analyses sanguines, ainsi que les contributions des pharmaciens pour assurer des soins sécuritaires et adaptés aux patients.
In this episode, Dr. Paul Wheatley-Price chats with Dr. Ines Menjak, Medical Oncologist at Sunnybrook Health Sciences Centre in Toronto, about the 2026 landscape of immunotherapy treatment for lung cancer. What exactly is immunotherapy, how does it work, when is it used, common side effects to expect, what are the latest drugs, and what's coming down the pipeline.
In this episode, Dr. Paul Wheatley-Price chats with Dr. Lisa Hicks, a hematologist-oncologist at St. Michael’s Hospital, who specializes in caring for medically and socially complex people with blood cancer. They talk about the unique neighbourhood that she serves in downtown Toronto, what are the social determinants of health, how various aspects of poverty and societal inequity might impact those with a lung cancer (or other cancer) diagnosis.
Dans cet épisode, la Dre Nathalie Daaboul s’entretient avec la Dre Myriam Bouchard, radio-oncologue au Centre Hospitalier Universitaire de Sherbrooke, afin de démystifier la radiothérapie dans le traitement du cancer du poumon. Ensemble, elles expliquent quand et pourquoi la radiothérapie est utilisée, les avancées qui rendent les traitements plus précis et mieux tolérés, comment les effets secondaires sont pris en charge, et pourquoi une approche humaine et multidisciplinaire est essentielle pour accompagner les patients tout au long de leur parcours de soins.
series, Dr. Paul Wheatley-Price chats with two guests, both with a depth of experience in ROS1+ lung cancer, a rare subtype of non-small cell lung cancer (NSCLC) which represents only about 1-2% of all lung cancer cases in Canada. Rev. Richard Reimer from Edmonton shares his story being diagnosed in 2009 with stage 4 lung cancer that was later identified as ROS1, and how he's been navigating life ever since. Dr. Geoffrey Liu is a Medical Oncologist at the Princess Margaret Cancer Center in Toronto and provides his clinical expertise on what is ROS1, how common is it, how does it get tested, and what the current treatment options are for those diagnosed with this rare subtype of lung cancer. This episode is dedicated to Richard's late beloved wife, Dana Rayment ❤️
Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec la Dre Catherine Labbé, pneumologue spécialisée en oncologie pulmonaire à l'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), au sujet de tout ce qu'il faut savoir sur le dépistage du cancer du poumon : qui est admissible, quels sont les critères et pourquoi est-il important de se faire dépister si vous présentez un risque élevé ?
In our new series called Perspectives on Lung Cancer, Dr. Paul Wheatley-Price sits down with two guests, both with a depth of experience in ALK+ lung cancer, which represents about 4-8% of all lung cancer cases in Canada. Dr. Cheryl Ho, medical oncologist at BC Cancer, provides her perspective as a physician treating these types of cancers in her daily practice, while Katie Hulan shares her journey as a patient diagnosed with ALK+ lung cancer in 2021, navigating the healthcare system, and her path to launching ALK Positive Canada to advocate for better awareness of this subtype of lung cancer.
Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec le Dr Kevin Jao, coprésident du comité médical consultatif de Cancer pulmonaire Canada et hémato-oncologue à l'Hôpital du Sacré-Cœur-de-Montréal. Ils présentent Cancer pulmonaire Canada, tout le soutien et les ressources disponibles pour les Canadiens touchés par le cancer du poumon, et mettent particulièrement l'accent sur le Mois de la sensibilisation au cancer du poumon.
In this episode, Dr. Paul Wheatley-Price is back for our annual recap of the IASLC 2025 World Conference on Lung Cancer (WCLC), which took place in Barcelona, Spain in early September. He is joined by two special guests: Dr. Barbara Melosky, Professor of Medicine at UBC and Medical Oncologist at BC Cancer, and Dr. Peter Ellis, Professor of Oncology at McMaster University and Medical Oncologist at Juravinski Cancer Center. They chat about all the updates for treatments like osimertinib for EGFR+ lung cancer, immunotherapy for small-cell lung cancer, and promising new treatments like for HER2 and ADCs coming down the pipeline.
Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec Lise Boilard, qui a reçu un diagnostic de cancer du poumon en 2017 à l'âge de 44 ans, et sa médecin traitante, la Dre Myriam Bouchard, radio-oncologue au Centre hospitalier de l'université de Sherbrooke. Lise partage son parcours inspirant face au cancer du poumon, la relation unique qu'elles ont nouée ensemble, ainsi que l'expertise du Dre Bouchard sur la maladie et la manière dont les patients peuvent mener une vie épanouie tout en gérant les symptômes et les traitements.
CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada. Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/
In this episode, Dr. Paul Wheatley-Price is back for another update into all the newest highlights from recent clinical trials for EGFR-positive lung cancer treatments. Dr. Stephen Liu is the Director of Thoracic Oncology and Professor of Medicine at Georgetown University in Washington, DC, and he co-hosts his own podcast with the IASLC, "Lung Cancer Considered". They are also joined by Emi Bossio, a passionate patient advocate who lives with EGFR+ lung cancer and has a number of roles, including as a member on LCC's Board of Directors.
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Andrew Robinson and Dr. Nathalie Daaboul on all the highlights coming out of this year's 2025 ASCO Conference, held in Chicago back in June. They discuss major developments in treatment for small cell lung cancer (SCLC), updates in immunotherapy, and a couple of unique drugs coming down the pipeline. Dr. Robinson is a Medical Oncologist and Associate Professor at Queen's University in Kingston, ON. Dr. Daaboul is a Medical Oncologist at L'Hôpital Charles Lemoyne in Montreal, Associate Professor at the University of Sherbrooke, and also the host of the Lung Cancer Voices podcast series in French!
In this episode, Dr. Paul Wheatley-Price chats with Dr. Adrian Sacher on everything there is to know about KRAS lung cancer. What is KRAS lung cancer, how is it tested, and what it means in terms of treatment options for those who have this subtype of lung cancer. Dr. Adrian Sacher is a Thoracic Medical Oncologist at the Princess Margaret Cancer Centre and Assistant Professor in the Departments of Medicine & Immunology at the University of Toronto.
In our special 100th episode, Dr. Paul Wheatley-Price reunites with the Current and Past Presidents of Lung Cancer Canada, to take a trip down memory lane on how lung cancer (and LCC) has evolved over the decades, what's happening now, and what's to come in the future! Dr. Paul Wheatley-Price is joined by our new President Dr. Rosalyn Juergens, and Past Presidents Dr. Stephanie Snow and Dr. Natasha Leighl. Watch the full video recording at https://youtu.be/tFfVVQvvf0s
In this episode, Dr. Paul Wheatley-Price chats with Claire Hopkins, Registered Dietician at the Princess Margaret Cancer Center, about all things nutrition and maintaining heathy eating habits for lung cancer patients. What exactly is the role of a dietician vs nutritionist, is sugar really bad for cancer, tips to maintain a healthy appetite, reasons behind weight loss during treatment, and the best supplements or meal alternatives.
Dans cet épisode, la Dre Nathalie Daaboul discute du processus d'investigation et de diagnostic du cancer du poumon avec la Dre Nicole Bouchard. La Dre Bouchard est pneumologue spécialisée en oncologie pulmonaire à l'Université de Sherbrooke et siège au comité consultatif médical de Cancer pulmonaire Canada.
In this episode, Dr. Paul Wheatley-Price and Dr. Renelle Myers discuss all there is to know about lung cancer screening in 2025 - what is lung cancer screening and why is it important, who can get screened, where it's available, and the latest technologies and advances in screening. Dr. Myers is an Interventional Pulmonologist and Clinician-Scientist at BC Cancer, and Clinical Associate Professor at the University of British Columbia.
In this episode, Dr. Paul Wheatley-Price chats with Dr. Dugald Seely, ND on naturopathic medicine and lung cancer - what is naturopathy vs alternative vs homeopathic medicine, how it can play a role within lung cancer care, the innovative research he's been doing, and busting some of the myths about CAM. Dr. Seely is a Naturopathic Doctor in Ottawa, CEO of the Center for Health Innovation, and Executive Director at the Patterson Institute for Integrative Oncology Research at the Canadian College of Naturopathic Medicine.
In this episode, Dr. Paul Wheatley-Price chats with Laura Floyd, a lung cancer advocate and comedian in BC to share her experience as a lung cancer patient, the importance of communication between patients and physicians, and even cracking a few jokes along the way!
In a special episode of Lung Cancer Voices, Dr. Paul Wheatley-Price sits down with Laura Greer, Senior VP & National Lead, Health & Wellness at Hill+Knowlton, for a timely discussion on what political change — or uncertainty — could mean for health policy, research funding, and advocacy? They chat about how the shifting political landscapes may impact healthcare: ripple effects of tariffs and economic pressures on patient care, cuts to NIH/HHS in the U.S. and what they mean for Canadian research, and how charities like Lung Cancer Canada can keep advocating — no matter the political climate.
In this episode, Dr. Paul Wheatley-Price sits down with Bev Moir, who's been living with stage 4 EGFR+ lung cancer since 2019, and her husband Ron Foreman. Bev and Ron share their experiences navigating this tough diagnosis, the important role that Ron plays as a caregiver supporting Bev throughout the journey, and what made Bev decide to use her voice as a platform and advocate for those living with lung cancer.
In this episode, Dr. Paul Wheatley-Price sits down with Christine Fader to share her husband Michael's experience being diagnosed with two cancers in his lifetime - throat cancer in 2018, then large cell lung cancer in 2020. Christine shares some of the difficult treatment experiences that Michael went through, the growing importance of trauma-informed care, navigating grief, and some tips for fellow caregivers around asking for support during tough times. Learn more about Christine's work and Michael's story at https://christinefader.com/about/
In this episode, Dr. Paul Wheatley-Price sits down with Amy Coupal, CEO of The Ontario Caregiver Organization (OCO) to talk about the current statistics and challanges that caregivers face, tips for balancing self-care, and how the OCO can support those caring for loved ones in Ontario and beyond. For information and support for caregivers, call the Ontario Caregiver Helpline at 1-833-416-2273 (available 24/7), or visit www.ontariocaregiver.ca
In this episode, Dr. Paul Wheatley-Price sits down with Tim Monds, Founder of Give A Breath 5K and Patient Advocate living with Stage 4 Lung Cancer. They talk about how Tim's personal journey with lung cancer inspired him to start the Give A Breath 5K walk/run in 2019, which has raised over $500,000 to date for support and research initiatives for those living with lung cancer, and now including the inaugural Give A Breath Research Award. Two awards of $25,000 each are available in support of advancements for patients with advanced or metastatic (i.e., stage III or IV) lung cancer; specifically, initiatives that apply to those beyond first-line therapy.Applications are now open for the Give a Breath Research Award until January 31, 2025.For more details on how to apply, visit https://lungcancercanada.ca/about-us/research-program/give-a-breath-research-award/
In our final episode of the year, Dr. Paul Wheatley-Price sits down with none other than the President of Lung Cancer Canada, Dr. Stephanie Snow, to reflect on all the progress we've made in the lung cancer community this year. From new treatments, diagnostic tools and screening updates, all the way to everything LCC has been up to this year, and our predictions for all the exciting things to come in 2025.Thank you for another year of Lung Cancer Voices!
In this episode, Dr. Paul Wheatley-Price chats with a familiar face for many Canadians - Kim MacDonald, a TV Broadcaster on The Weather Network for over 25 years. In December 2016, Kim was diagnosed with stage 2B breast cancer and underwent numerous treatments including a double mastectomy. She talks about her experience living with cancer, her decision to share such a personal journey with her audience publicly, and the lessons she'd learned along the way. Check out Kim's blog at https://www.kmacblog.com/
La Dre Nathalie Daaboul s’entretient avec Julie Desjardins de la vallée d'Annapolis, en Nouvelle-Écosse, dans notre premier épisode du balado en français Voix du cancer du poumon. Julie lutte contre un cancer du poumon ALK+ de stade IV depuis qu’elle a reçu un diagnostic inattendu en juillet 2022, alors qu’elle n’avait que 39 ans. Elle fait part de son histoire inspirante et de la façon dont le cancer a changé sa vision de la vie dans cet épisode.
In this episode, Dr. Paul Wheatley-Price chats with Sonia Turingia who was diagnosed with Stage 4 lung cancer in Spring 2023. Sonia shares her journey being diagnosed with cancer, navigating the challenges during treatment, why she believes it's important to self-advocate, and how to do that without anger.
In this episode, Dr. Paul Wheatley-Price chats with Dr. Peter Ellis, Thoracic Medical Oncologist at the Juravinski Cancer Center and Professor at McMaster University about the highlights at this year's annual World Conference of Lung Cancer (WCLC) in San Diego and European Society of Medical Oncology (ESMO) Conference in Barcelona. Some very exciting updates with immunotherapy in early and advanced lung cancers, and the patient perspectives on clinical trials!
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Geoffrey Liu, Medical Oncologist at Princess Margaret Cancer Center and a Canadian leader in opening dozens of clinical trials. Dr. Liu gives a rundown of everything you need to know about ALK-positive lung cancer - what is ALK, how common is it, how this type of lung cancer is treated, and some of the most recent clinical trial updates.
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Christopher Booth, Medical Oncologist and Health Services Researcher at Queen’s University, to talk about Common Sense Oncology. CSO is an initiative Started by Dr. Booth amongst Canadian and global partners to ensure that patients have access to cancer treatments that provide meaningful improvements in outcomes that matter irrespective of where they live or their healthcare system. Learn more at https://commonsenseoncology.org/
In this episode, Dr. Paul Wheatley-Price chats with Dr. Stephanie Mercier, Medical Oncology Resident at the University of Ottawa & Dr. Stephen Lam, Respirologist and Lead of the BC Screening Program at the University of British Columbia. They talk about the recent paper they published together highlighting the significant Canadian contributions to the field of lung cancer, current challenges, and future directions. Read the full article at https://doi.org/10.1080/24745332.2023.2255193
In this episode, Dr. Paul Wheatley-Price sits down with Shannon Farley, a Nurse Practitioner (NP) at the William Osler Health System in Brampton, ON. They chat about what an NP is and the difference with other types of nurses, current challenges in the ERs and how nurses play a role in "diverging" cancer patients away from the emergency room, and the role they play in a patients' oncology team.
In this episode, Dr. Paul Wheatley-Price and Dr. Rosalyn Juergens, Medical Oncologist at the Juravinski Cancer Center and Co-Chair of LCC's Medical Advisory Committee, discuss the top highlights in lung cancer research presented at the 2024 ASCO Annual Conference held in Chicago this past June.
In this episode, Dr. Paul Wheatley-Price sits down with guests Dr. Lacey Pitre, Medical Oncolgist & Dr. Stacey Santi, Medical Research Chair at Health Sciences North in Sudbury, Ontario. Drs. Pitre and Santi are one of the recipients of a $100,000 research grant offered jointly by Pfizer Canada, Lung Cancer Canada, Lung Health Foundation, and Association pulmonaire du Québec. They explain their research project focusing on tackling and improving disparities and equities in clinical trial access for patients with metastatic lung cancer in rural/remote communities.
In this episode, Dr. Paul Wheatley-Price chats with Dr. Michela Febbraro and Dr. Silvana Spadafora, Medical Oncologists at the Algoma District Cancer Centre in Sault Ste. Marie, ON and also, mother-and daughter-duo. They talk about the joys, challenges, and everything in between of living and caring for patients with lung cancer in rural and remote communities in Northern Ontario.
In today's episode, Dr. Paul Wheatley-Price sits down with Dr. Alain Tremblay, Professor of Medicine and Respirologist at the University of Calgary and Medical Lead of the Alberta Lung Cancer Screening program. Dr. Tremblay is the winner of the 2023 Geoffrey Ogram Memorial Research Grant for his project on implementing artificial intelligence (AI) to interpret lung cancer screening examinations for better accuracy of readings and to improve efficiency in the patient pathway. Applications for the 2024 Geoffrey Ogram Memorial Research Grant are now open! Learn more about the grant opportunity at bit.ly/GOMRG
In this episode, Dr. Paul Wheatley-Price sits down with Nina Snyder, Chief Operations Officer at Alberta Lung. Nina introduces Alberta Lung as an organization and what they do to support Albertans living with lung disease, factors like radon and air quality that may lead to a lung cancer diagnosis, challenges like isolation, youth vaping and e-cigarettes, and how lung cancer screening is shaping up across the province. Check out Alberta Lung at www.ablung.ca We also did a collaboration with Alberta Lung's The Unsung Lung Podcast, where Dr. Paul Wheatley-Price and Dr. Quincy Chu spoke about how the Lung Cancer Voices podcast came to be, new treatments in lung cancer, and what drew them to pursue a career in oncology. Check out their podcast at https://jsperlingg4.podbean.com/e/the-c-word/
In this episode, Dr. Paul Wheatley-Price sits down with Dr Rosalyn Juergens, Medical Oncologist at the Juravinski Cancer Center in Hamilton, ON and Chair of LCC's Medical Advisory Committee. Dr. Juergens is one of the winners of the Quality Improvement Grant aimed at elevating the care and outcomes of Canadians living with metastatic NSCLC. She chats about her ambitious research proposal focusing on opportunities for liquid vs. solid tissue biopsies in community hospitals in Central-West Ontario, and the inequities and barriers that patients in rural communities face in healthcare and in turn leading to delayed diagnosis. The grant is offered in collaboration between Lung Cancer Canada, the Lung Health Foundation, the Quebec Lung Association, and Pfizer Canada, with up to $200,000 to be awarded. For more information, please visit https://www.pfizer.ca/en/media-centre/the-lung-health-foundation-lung-cancer-canada-the-quebec-lung-association-and-pfizer-canada-announce-recipients-of-the-2023-national-quality-improvement-grant-program-to-support-canadians-living-with-lung-cancer
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Amir Safavi, final-year Radiation Oncology Resident at the University of Toronto, and Dr. Jillian Tsai, Staff Radiation Oncologist at Princess Margaret Cancer Centre. They preface the chat with radiation 101, describe what "oligo-" means in the context of oligoradiation, oligometastises & oligoprogression, the possibility of combining oligoradiation with other cancer treatments, and finally, the CURB research study they're working on to test whether they could use stereotactic radiotherapy to stop oligoprogression.
In this episode, Dr. Paul Wheatley-Price speaks to the team of The Palliative Care Early and Systematic (PaCES) Project out of the University of Calgary: Dr. Jessica Simon, Associate Professor and Head of the Division of Palliative Medicine; Lisa Shirt, RN, Clinical Nurse Specialist; and Tim Monds, stage 4 lung cancer survivor. What is the PaCES project, the benefits of early palliative care for lung cancer patients, and are there plans to get this project going outside of Alberta?Learn more about the PaCES program at https://cumming.ucalgary.ca/research/paces-project
In the second episode of our "Research in Canada" series, Dr. Paul Wheatley-Price meets with Dr. Enam Alsrayheen, Health Outcomes Scientist at Cape Breton Regional Hospital, who is a recipient of the 2023 Geoffrey Ogram Memorial Research Grant. Dr. Alsrayheen speaks about her research implementing a community lung clinic in the rural areas of Cape Breton, and the accessibility barriers these resolve for Canadians.
In the first episode of our "Research in Canada" series, Dr. Paul Wheatley-Price speaks with Dr. Alison Wallace, Thoracic Surgeon and Associate Professor, Dalhousie University, recipient of a 2023 Lung Ambition Award. Dr. Wallace speaks about her research project focused on improving female patients’ quality of life when undergoing lung cancer surgery.For more information about the 2024 Lung Ambition Awards, visit www.lccresearch.ca
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Vishal Navani, Medical Oncologist at the Tom Baker Cancer Centre, and Dr. Andrea Fung, Thoracic Medical Oncologist in Kingston Health Sciences Centre. They chat about the latest developments in lung cancer research at the 2023 ESMO conference in Madrid, Spain this past October.
In this special episode from our 2023 Evening of Hope, Dr. Paul Wheatley-Price sits down with Dann Wonser, lung cancer survivor and advocate in Portland, OR. Dann dives into his journey with lung cancer and beating the odds of survival once handed to him, sharing his inspiring journey with others, and his most recent venture in writing his book, Second Wind: Thriving With Cancer. Until November 15, 2023, you can get Dann's book, Second Wind: Thriving with Cancer, for free as an e-book. Get your copy today https://www.amazon.ca/dp/B07C9BWWB7/ref=docs-os-doi_0. Read more about Dann's journey on his blog at https://www.dannwonser.com/
In this second installment of the two-part "Best of WCLC 2023" series, Dr. Paul Wheatley-Price continues the conversation with Dr. Cheryl Ho, Medical Oncologist at BC Cancer, and Dr. Jonathan Riess, Professor of Medicine at UC Davis in California, to discuss the highlights of this year's World Conference in Lung Cancer in Singapore. This episode focuses on the outcomes from the MARS 2 study in the UK on surgery in mesothelioma. Listen to Part 1 of the Best in WCLC 2023 Podcast at https://on.soundcloud.com/sntfe
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Cheryl Ho, Medical Oncologist at BC Cancer, and Dr. Jonathan Riess, Professor of Medicine at UC Davis in California, to discuss the highlights of this year's World Conference in Lung Cancer in Singapore. A new wave of drugs for lung cancer, unique screening projects from around the globe, and even some chili crab stories!
In this eye-opening episode, Dr. Paul Wheatley-Price sits down with Dr. Sara Moore, Medical Oncologist at The Ottawa Hospital, on the topic of Medical Assistance in Dying (MAID). What is MAID, the history behind it, how MAID works, and alternatives to MAID.
Lung Cancer Canada acknowledges this may be a sensitive and emotional topic for some listeners. This podcast will not discuss the ethics or opinions behind MAID.
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Natasha Leighl, Medical Oncologist and Lung Site Lead at Princess Margaret Cancer Center on the highly requested topic of Treatment Upon Progression: What's Next. Where and why do cancers become drug-resistant, what can we do about it, the challenges of the regulatory process for new treatments, and access to additional testing - all answered in this episode.
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Shantanu Banerji, Associate Professor at UManitoba and Medical Oncologist at CancerCare Manitoba, and Dr. Parneet Cheema, Director of Cancer Care and Medical Oncologist at William Osler Health System, about all the new developments at ASCO this year.
In this episode, Dr. Paul Wheatley-Price sits down with Filomena Servidio-Italiano, Founder, President & CEO of the Colorectal Cancer Resource and Action Network (CCRAN) about her Uncle Sergio Servidio's journey with lung cancer, and her role as a caregiver.
To read Uncle Sergio's story, visit http://bit.ly/SergioServidio
In this episode, Dr. Paul Wheatley-Price chats with Dr. David Gandara, Thoracic Oncologist and Professor Emeritus at UC Davis, Sacramento, CA about all things immunotherapy. What is immunotherapy, how does it work, should early-stage patients consider immunotherapy, and why doesn't it work on patients with specific driver mutations?Listen to our previous episode on immunotherapy at https://on.soundcloud.com/RSTC8
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Dan Breadner, Assistant Professor in Medical Oncology at the University of Western Ontario, about everything you need to know about EGFR-Positive Lung Cancer. What is EGFR, how do you test for it, and what's the latest in EGFR lung cancer research? All these questions answered in our latest episode!For more information on EGFR-positive lung cancer, listen to our previous episode on the topic at https://on.soundcloud.com/Wp6xU
In this episode, Dr. Paul Wheatley-Price sits down with Dr. Cheryl Ho, Clinical Associate Professor at UBC and medical oncologist at BC Cancer Agency, about all things clinical trials. What is a clinical trial and why are they important? Why is there eligibility criteria and what happens if i don't meet them? Are they really safe? All these questions(and more)answered in this final episode of the year.
In this episode, Dr. Paul Wheatley-Price sits down with Andrea Redway, a stage 4 lung cancer patient in Ottawa, ON about her inspiring cancer journey and how she grew into being the incredible advocate about the disease that she is today.
In this episode, Dr. Paul Wheatley-Price sits down with Dr. David Dawe, Medical Oncologist at Cancer Care Manitoba, and Dr. Stephanie Snow, President of LCC and Medical Oncologist at QEII Health Sciences Center to discuss their experiences and highlights at the ESMO Congress this past September in Paris, France.
Dans notre premier podcast en français, l'oncologue médical Dr. Normand Blais parle avec Catherine Larose, survivante d'un cancer du poumon de stade 4 et défenseure passionnée des patients, au cours de son parcours.
In our first French podcast, medical oncologist Dr. Normand Blais speaks with Catherine Larose, stage 4 lung cancer survivor and passionate patient advocate on her journey.
In part 2 of this series, Dr. Paul Wheatley-Price speaks to lung cancer survivor and tireless advocate, Angus Pratt on his involvement on an advisory council for research with the Canadian Cancer Society, and recent experience attending medical conferences as a patient. Visit Angus' blog at https://journey.anguspratt.ca/
In this episode, Dr. Paul Wheatley-Price speaks to lung cancer survivor and tireless advocate, Angus Pratt. Angus details his cancer journey and how his diagnosis worked his way into becoming an advocate in the lung cancer space. Visit Angus' blog at https://journey.anguspratt.ca/
In this episode, Dr. Paul Wheatley-Price speaks to Dr. Nicole Culos-Reed, professor at the University of Calgary and lung cancer patient Duane Kelly on the importance of exercise for lung cancer patients, its numerous health benefits, and the national EXercise for Cancer to Enhance Living well (EXCEL) program. Duane shares his lung cancer journey and how participating in EXCEL has improved his life while living with cancer.
The next session for those of the EXCEL Program will begin in September 2022! Visit thriveforcancersurvivors.com for more information and how to participate.
In this episode, Dr. Paul Wheatley-Price speaks to Dr. Andrea Fung of the Kingston Health Sciences Center, and Dr. Shaqil Kassam of the Southlake Regional Health Centre on the key takeaways and highlights at the ASCO 2022 Annual Meeting in Chigago earlier in June.
In this episode, Dr. Paul Wheatley-Price speaks to lung cancer survivor Stephen Sollows about his life, faith, cancer journey and the story of the current #HopeArmy t-shirt design. To purchase your own tee, visit https://www.hopearmy.ca/.
In this episode, Dr. Paul Wheatley-Price speaks to Dr. David J. Stewart of the Ottawa Hospital about his new book "A Short Primer on Why Cancer Still Sucks", which addresses common, vexing questions about cancer and what future changes we can anticipate. You can purchase the book online at Chapters/Indigo, Barnes and Noble, or Amazon. To read the poem, "Say not the Struggle nought Availeth", visit: https://bit.ly/3Gifg57.
Part 4 of the series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.
Part 3 of the series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.
Part 2 in this series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.
In the first of a series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.
Continuing our special series, What's New In: Dr. Wheatley Price discusses new advances in Radiotherapy with Dr. Corinne Faivre-Finn of the NHS Foundation Trust and Dr. David Palma of the London Health Sciences Centre. This webinar aired on December 1, 2021,
In this special episode that aired as a webinar in our What's New In: series, Dr. Paul Wheatley-Price discusses the newest and upcoming treatments for rare cancer subtypes like RET, MET, HER2 and more with Dr. Alexander Drilon of the Memorial Sloan Kettering Cancer Center, and Dr. Parneet Cheema of the William Osler Health System
In this episode, Dr. Wheatley-Price speaks to lung cancer survivor, Terry Morey and his wife, Joyce Morey about Terry's cancer journey and the invaluable role of a caregiver.
In this episode, Dr. Paul Wheatley-Price speaks to Dr. Doreen Ezeife, Tom Baker Cancer Centre, Calgary, and Dr. Rosalyn Juergens, Juravinski Cancer Centre, Hamilton, about the highlights of lung cancer research in 2021.
In this special edition, we present our previously recorded webinar What's New In: Mesothelioma, a moderated discussion of new treatments, techniques and protocols in mesothelioma. Co-hosted by the Canadian Mesothelioma Foundation. For more information visit: https://cmfonline.org
Dr. Paul Wheatley-Price sits down with Dr. Gwyn Bebb in this week's episode of Lung Cancer Voices to discuss the importance of lung cancer research.
In this throwback episode with the 2021 International Association for the Study of Lung Cancer conference taking place, Dr. Paul Wheatley-Price interviews Kirsten Ito, Associate Director, IASLC Foundation and Patient Advocacy, about the opportunities for patient involvement with the IASLC. Registration to the 2021 virtual conference, taking place now until Sept 14, 2021, is free for patients and caregivers. Registration link: https://wclc2021.iaslc.org/registration/.
In this episode, we present our next edition of What's New In: a moderated discussion of the findings presented at the American Society for Clinical Oncology Conference held Jun 4-8, 2021.
In this episode, Dr. Paul Wheatley-Price speaks with Tim Monds, retired Educator, School Superintendent and lung cancer survivor
In this eye-opening episode, Dr. Paul Wheatley-Price speaks to Dr. Hsien Seow, PhD and Dr. Samantha Winemaker, MD. They dispel the myths and promote the benefits of early palliative care for lung cancer patients. They are the creators of the 5 star rated Waiting Room Revolution podcast, which can be found here: https://www.waitingroomrevolution.com/
This episode was originally recorded as a webinar in our What's New In: series held on Mar 26, 2021. Dr. Julie Brahmer, MD, Johns Hopkins Medicine and Dr. Rosalyn Juergens, MD, PhD, Juravinski Cancer Centre, discuss the latest advances in immunotherapy for the treatment of lung cancer. Moderated by Dr. Paul Wheatley-Price.
In this episode, Dr. Anne Gonzalez, MD, MSc, McGill University Health Centre, winner of the 2020 Lung Cancer Canada Geoffrey Ogram Memorial Research Grant, discussed her research on predicting risk of lung cancer in patients with COPD.
In this episode, Paul Wheatley-Price speaks to Elya Martinson, mom of 3, university student, and lung cancer "thriver", who was diagnosed during COVID-19.
In this episode, Dr Paul Wheatley-Price interviews Darin Diehl, content marketing thought leader, journalist, and lung cancer patient diagnosed during COVID-19.
Join us for another special episode from our What's New In: webinar series. This episode is a discussion of findings presented at the Canadian Lung Cancer Conference held February 9-10, 2021. Moderated by Dr. Paul Wheatley-Price and Featuring Dr. Justin Gainor, MD, Medical Oncologist, Massachusetts General Hospital, Boston and Dr. Cheryl Ho, MD, FRCP(C), Medical Oncologist BC Cancer, Vancouver.
The next in our Webinar Series: What's New In, in this episode, Dr. Paul Wheatley-Price discusses upcoming treatments, studies breakthroughs, and the future of lung cancer with Dr. Frances Shepherd, MD, FRCPC, Medical Oncologist at Princess Margaret Hospital in Toronto.
In this special episode we continue our webinar series, What's New In: with Dr. Paul Wheatley-Price moderating a discussion of ALK positive lung cancer and treatments. Featuring Dr. Natasha Leighl, BSc, MMSc, MD, Medical Oncologist, Princess Margaret Hospital and Dr. Ross Camidge, MD, PhD, Medical Oncologist, University of Colorado Hospital.
In this special podcast, we present the premiere episode of our webinar series: What's New In:. This episode is a moderated discussion of EGFR positive lung cancer that includes the beginning and evolution of treatment, current treatments, and what’s next.
In this episode, Dr. Paul Wheatley Price speaks to Dr. Matthew Steliga, Thoracic Surgeon, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR about the benefits of quitting smoking and new tools to help patients quit.
In this episode, Dr. Paul Wheatley-Price speaks with Natalie Fitzgerald, Director, Performance, and Erika Nicholson, Director, Screening & Atlantic Region Lead of the Canadian Partnership Against Cancer (CPAC) about the CPAC report: "Lung cancer and equity: A focus on income and geography" and the findings that influence treatment and outcomes for patients. To read the report, visit: https://www.partnershipagainstcancer.ca/topics/lung-cancer-equity/
In this special edition tie-in with The 2020 Faces of Lung Cancer Report, Dr. Paul Wheatley-Price speaks with Natalie Fitzgerald, Director, Performance, and Erika Nicholson, Director, Screening & Atlantic Region Lead of the Canadian Partnership Against Cancer (CPAC) about the impact that screening could have on the incidence of lung cancer and some of the initiatives that CPAC has implemented. For more information about screening and lung cancer in Canada, read our 2020 Faces of Lung Cancer Report here: https://www.lungcancercanada.ca/LungCancerCanada/media/Documents/LCC-2020-FOLCR-ENG.pdf
In this episode, Dr Paul Wheatley-Price speaks once again to Dr Kevin Jao, who is a medical oncologist drafted to treat COVID-19 in Montreal. For more information on COVID-19 and lung cancer, read the 2020 Faces of Lung Cancer COVID-19 insert, available here: https://www.lungcancercanada.ca/LungCancerCanada/media/Documents/COVID-19-Report-ENG-(1).pdf
In this special edition for Lung Cancer Awareness Month, Dr. Paul Wheatley-Price talks to Dr. Brandon Sheffield, Pathologist, William Osler Health about how biomarker testing is done and how it can change treatment plans. For more information about testing, treatment and screening in Canada, read our 2020 Faces of Lung Cancer Report here: https://bit.ly/2020FOLC
In this episode, Dr. Paul Wheatley-Price speaks with Allice Legat, a practicing anthropologist in the Northwest Territories, published author and lung cancer survivor.
In this special podcast, we present part 2 of "Highlights from ASCO and World Lung 2020" , which was originally broadcast as a webinar on August 14, 2020, hosted by Dr. Paul Wheatley-Price and featuring: Dr Sanjay Popat, BSc, MBBS, FRCP, MD, Medical Oncologist, Royal Marsden Hospital, London Dr Jonathan Riess, MD, MS, Medical Oncologist, UC Davis Cancer Centre, Sacramento Dr Rosalyn Juergens, MD, PhD, Medical Oncologist, Juravinsky Cancer Centre, Hamilton, The webinar was a 1 hour live round table discussion that shared highlights from the 2020 American Society of Clinical Oncology (ASCO) meeting and the 2020 International Association for the Study of Lung Cancer (IASLC) World Conference Lung Cancer (WCLC) Presidential Symposium.
In this special podcast, we present part 1 of "Highlights from ASCO and World Lung 2020" , which was originally broadcast as a webinar on August 14, 2020, hosted by Dr. Paul Wheatley-Priceand featuring: Dr Sanjay Popat, BSc, MBBS, FRCP, MD, Medical Oncologist, Royal Marsden Hospital, London Dr Jonathan Riess, MD, MS, Medical Oncologist, UC Davis Cancer Centre, Sacramento Dr Rosalyn Juergens, MD, PhD, Medical Oncologist, Juravinsky Cancer Centre, Hamilton, The webinar was a 1 hour live round table discussion that shared highlights from the 2020 American Society of Clinical Oncology (ASCO) meeting and the 2020 International Association for the Study of Lung Cancer (IASLC) World Conference Lung Cancer (WCLC) Presidential Symposium.
In this special edition for World Lung Cancer Day, Dr. Paul Wheatley-Price moderates a debate between Dr. Parneet Cheema, Medical Oncologist, William Osler Health, and Dr. Randeep Sangha, Medical Oncologist, Cross Cancer Institute, on whether recent advances in detection and treatment have made lung cancer a chronic disease.
In this “Throwback” episode released 1 year ago, Dr. Paul Wheatley-Price interviews lung cancer survivor Mariel Bouris. A special thank you to the Bouris family for providing the funding for the beginning of our program!
In this episode, Dr. Paul Wheatley-Price speaks to Dr. Renelle Myers, Interventional Respirologist, BC Cancer, about her study, Breathomics For the Early Detection of Lung Cancer in Never Smokers. Dr. Myers is the inaugural recipient of Lung Cancer Canada's Geoffrey Ogram Memorial Research Grant, made possible by the Ogram Family.
In this episode, Dr. Paul Wheatley-Price speaks to Kelly Zibrik, Nurse Triage Coordinator, BC Cancer, Bonnie Leung, Nurse Practitioner, BC Cancer and Leslie Markin, Clinical Trials Nurse Coordinator, BC Cancer, about their role in providing health care for lung cancer patients.
In this episode, Dr. Paul Wheatley-Price, Dr. Stephanie Snow, Medical Oncologist, QEII Hospital and Chair of the LCC Medical Advisory Committee, and Dr. Quincy Chu, Medical Oncologist, Cross Cancer Institute and Member of the LCC Medical Advisory Committee discuss the near future and potential advancements of lung cancer treatment.
In this special episode, Christina Sit, Programs Director at Lung Cancer Canada asks Dr. Paul Wheatley-Price the most common questions about COVID-19 that we have heard from lung cancer patients.
In this episode, Dr. Paul Wheatley-Price speaks to Kirstin Ito, Patient Advocacy Manager at the International Association for the Study of Lung Cancer about how patients can get involved in their programs. Note that the programs mentioned in the podcast have an application deadline of Mar 27, 2020. https://www.iaslc.org/
In this episode. Dr. Paul Wheatley-Price interviews Bonnie Addario, Lung Cancer Survivor, Patient Advocate and founder of the Go2Foundation for Lung Cancer. Visit the Foundation here: https://go2foundation.org/
in this episode Dr. Paul Wheatley-Price interviews Dr. Eric Lim, Professor of Thoracic Surgery at Royal Brompton Hospital. Visit Dr. Lim's website at: https://www.drericlim.com
In this episode Dr. Paul Wheatley-Price discusses the highlights of the IASLC World Lung Conference with Drs. Tom John and Kevin Jao.
In this episode Dr. Paul Wheatley-Price talks to Dr. David Palma about radiotherapy, navigating cancer treatment, and his book, "Taking Charge of Cancer: What You Need to Know to Get the Best Treatment".
In this episode, Dr. Paul Wheatley-Price speaks to 4 year lung cancer survivor Donald Monk and his partner Peter Mitchell.
In a special episode to commemorate the anniversary of the legalization of recreational cannabis, Dr. Paul Wheatley-Price talks to Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado, about the myths and facts surrounding cannabis and the treatment of lung cancer
In this episode, Dr. Paul Wheatley-Price speaks to Kim Moran MacIntosh. Kim is a 2 year survivor of stage IV, EGFR +ve non small cell lung cancer.
In this special edition of the podcast, Dr. Paul Wheatley-Price discusses the most exciting research presented at the IASLC World Lung Cancer Conference 2019 in Barcelona with Dr. Tom John, Medical Oncologist, Olivia Newton-John Cancer Research and Wellness Centre and Dr. Kevin Jao, Medical Oncologist, Hôpital du Sacré-Cœur de Montréal.
In this episode, Dr. Paul Wheatley-Price speaks with Diane Manii, Oncology Social Worker, The Ottawa Hospital, about the benefits of support for lung cancer patients
Dr. Paul Wheatley-Price interviews Dr. Jack West of the Swedish Cancer Institute in Seattle, founder of GRACE -Global Resource for Advancing Cancer Education. Visit his website at http://jackwestmd.com/
In this episode, Dr. Paul Wheatley-Price interviews Dr. Stephen Lam, the principal investigator for the pan-Canadian Lung Cancer Screening Program.
In this episode, Dr. Paul Wheatley-Price interviews Mariel Bouris, a retired nurse and multi-year small cell lung cancer survivor.
On our first podcast, Dr. Paul Wheatley-Price, Medical Oncologist at The Ottawa Hospital and President of Lung Cancer Canada, speaks to Dr. Natasha Leighl, Medical Oncologist at Princess Margaret Hospital and Dr. David Gandara of UC Davis, Sacramento. For more information on lung cancer visit www.lungcancercanada.ca